Videos

Pharmacists highlight patient hesitations surrounding vaccinations and offer a multitude of approaches for alleviating these concerns.

Insights on unmet needs in HR-positive, HER2-negative treatment management and on how pharmacists can optimize treatment strategies and patient outcomes.

The panel highlights opportunities for inclusive populations within trials for HR+/HER2- breast cancer, as well as pharmacist-led initiatives in clinical trial settings.

The first thing is educating these folks, because it's hard for them to understand our challenges if they don’t understand what we do.

Get involved, attend their sessions, attend their conferences, understand what they’re saying, make sure that we’re, again, speaking with that one common voice.

You just need to tell your story and be genuine and be real, and it makes such a difference.

We have to have this one voice that we've been talking about, this one consistent message.

Whether it was the ability to vaccinate, whether it was the ability to test, whether it's now the ability to prescribe Paxlovid for patients, those are big progress moves for the profession of pharmacy.

Daniel Gagnon, VP of Global UPS Healthcare, discusses vaccine equity panel discussion at the UPS Impact Summit in Atlanta, which was held at the National Center for Civil and Human Rights.

The experts provide their closing thoughts and discuss unmet needs in the treatment of patients with MCL.

Drs Haumschild, Jain, and Wang evaluate MCL therapies under investigation and the impact on the future of MCL treatment.

Key opinion leaders evaluate treatment options for MCL while emphasizing payer considerations.

When we talk about access, that is a pharmacist.

Health Mart University also offers "basic technician training programs," to allow pharmacies to bring those new technicians on board, help them meet the PTCB examination standards, and really get that new technician ready to go.

The panel concludes with their thoughts on the future of the AML treatment landscape.

Drs McCoy and McCloskey discuss relapsed/refractory AML, including treatment goals and options.

Health Mart was able to deliver the targeted education they needed in a virtual manner to allow them to start in the uniting and to keep their immunization credentials.

We need to be able to build on that momentum, and at the same time, we need sustainable reimbursement models.

Health Mart University started as a platform to be franchise standards.

There's a lot of complexity in the agreements, so pharmacies like Health Mart Atlas provide reporting and resources.

Pharmacists discuss the impacts of inaccuracy on vaccine hesitancy and offer communication strategies for conversations with patients.

Ed Cohen, PharmD, FAPhA, holds a panel discussion exploring pharmacist-provided immunizations, focusing on COVID-19–specific updates and recommendations.

Pharmacies need to kind of move beyond those models that are more punitive and look for true pharmacy-based measures and the ability to pay for performance and outcomes for patients.

It's really been a challenge for Health Mart pharmacies with the labor market the way that it is.

Heather N. Moore, PharmD, BCOP, CPP, drives a discussion on the role of pharmacists in treatment strategy and optimizing patient adherence to HR+/HER2- breast cancer treatment.

The panel explore emerging treatment pathways in HR+/HER2- breast cancer and the impacts on care management and patient outcomes.

PSAO supports community pharmacies through patient access by unlocking the right payer agreements.

At the end of the day, we're interdisciplinary in terms of how it is that we need to manage our patients.

What we're seeing as a trend is this significant increase in synthetic opioids, specifically fentanyl, being contaminated and causing severe overdoses.

Donald Miller, PharmD, discussed how the recent Supreme Court decision overturning Roe v. Wade has created confusion around access to methotrexate for patients in some states that are limiting abortion access.